Log in
Enquire now
User profile

Arlene Garner

Biologist
Joined October 2022
9
Contributions
ContributionsActivity
Regeneron PharmaceuticalsRegeneron Pharmaceuticals was edited byArlene Garner profile picture
Arlene Garner
October 2, 2022 11:37 pm
Infobox
Patents
‌
US Patent 11421036 Methods of treating eosinophilic esophagitis by administering an antibody which inhibits interleukin-4 receptor (IL-4R)
0
Regeneron PharmaceuticalsRegeneron Pharmaceuticals was edited byArlene Garner profile picture
Arlene Garner
October 2, 2022 11:37 pm
Infobox
Patents
‌
US Patent 11428695 Concentration-dependent self-interaction assay
0
Regeneron PharmaceuticalsRegeneron Pharmaceuticals was edited byArlene Garner profile picture
Arlene Garner
October 2, 2022 11:36 pm
Infobox
Patents
‌
US Patent 11435359 Dual-column LC-MS system and methods of use thereof
0
Regeneron PharmaceuticalsRegeneron Pharmaceuticals was edited byArlene Garner profile picture
Arlene Garner
October 2, 2022 11:36 pm
Infobox
Patents
‌
US Patent 11433186 Devices and methods for precision dose delivery
0
Regeneron PharmaceuticalsRegeneron Pharmaceuticals was edited byArlene Garner profile picture
Arlene Garner
October 2, 2022 11:35 pm
Infobox
Patents
‌
US Patent 11434300 Methods and antibody compositions for tumor treatment
0
Regeneron PharmaceuticalsRegeneron Pharmaceuticals was edited byArlene Garner profile picture
Arlene Garner
October 2, 2022 11:35 pm
Infobox
Patents
‌
US Patent 11440950 Anti-VEGF protein compositions and methods for producing the same
0
Regeneron PharmaceuticalsRegeneron Pharmaceuticals was edited byArlene Garner profile picture
Arlene Garner
October 2, 2022 11:35 pm
Infobox
Patents
‌
US Patent 11439683 Anti-angiogenic therapy of metastatic colorectal cancer
0
‌
US Patent 11439758 Devices and methods for precision dose delivery
0
Regeneron PharmaceuticalsRegeneron Pharmaceuticals was edited byArlene Garner profile picture
Arlene Garner
October 2, 2022 11:34 pm
Infobox
Patents
‌
US Patent 11448651 Modifying binding molecules to minimize pre-exisiting interactions
0
Regeneron PharmaceuticalsRegeneron Pharmaceuticals was edited byArlene Garner profile picture
Arlene Garner
October 2, 2022 11:34 pm
Infobox
Patents
‌
US Patent 11446389 Maytansinoid derivatives, conjugates thereof, and methods of use
0